BioStock Investor Meeting: Interview with OssDsign

29 September 2022 - 08:40

In connection with the BioStock Investor Meeting in Stockholm, BioStock’s reporter was visited by Anders Svensson, CFO of OssDsign. Svensson told us more about OssDsign’s products for regenerative implants and patient-specific solutions for the treatment of bone defects. He also answered the question of what distinguishes OssDsign’s products from competitors and elaborated on the company’s road map for growth.

Read the article at

This is a press release from BioStock - Connecting Innovation & Capital

Provided by: Cision
Nasdaq First North GM Stockholm (Sweden)
OssDsign AB
OssDsign is a designer and manufacturer of implants and material technology for bone regeneration. The products include OssDsign Cranial and CranioPlug....
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More